Loading clinical trials...
Loading clinical trials...
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia
Conditions
Interventions
Azficel-T (autologous fibroblasts)
Placebo
Locations
3
United States
Surgery/Head and Neck, David Geffen School of Medicine at UCLA
Los Angeles, California, United States
Dept of Otolaryngology, Stanford Univ Medical Center
Stanford, California, United States
NYU Langone Medical Center
New York, New York, United States
Start Date
March 1, 2014
Primary Completion Date
April 1, 2016
Completion Date
December 21, 2016
Last Updated
June 3, 2021
Lead Sponsor
Castle Creek Biosciences, LLC.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions